Genmab
GMAB
GMAB
237 hedge funds and large institutions have $1.94B invested in Genmab in 2022 Q4 according to their latest regulatory filings, with 66 funds opening new positions, 75 increasing their positions, 79 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
5% less repeat investments, than reductions
Existing positions increased: 75 | Existing positions reduced: 79
25% less call options, than puts
Call options by funds: $1.09M | Put options by funds: $1.45M
Holders
237
Holding in Top 10
2
Calls
$1.09M
Puts
$1.45M
Top Buyers
| 1 | +$33.8M | |
| 2 | +$23.6M | |
| 3 | +$20.2M | |
| 4 |
Franklin Resources
San Mateo,
California
|
+$18.3M |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$16.5M |
Top Sellers
| 1 | -$39.4M | |
| 2 | -$34M | |
| 3 | -$21.6M | |
| 4 |
CCM
CAAS Capital Management
New York
|
-$11.2M |
| 5 |
HJGA
Hardman Johnston Global Advisors
Stamford,
Connecticut
|
-$10.2M |